AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2018
Jun 5, 2018
29777_dirs_2018-06-05_75b7b82b-eddc-4bad-b06c-5fe8900af742.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-06-01
Reporting Person: LANE ANDREW H (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-01 | Common shares without par value | A | 3007 | — | Acquired | 36276 | Direct |
| 2018-06-01 | Common shares without par value | F | 602 | $61.53 | Disposed | 35676 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 1239 | Indirect |
Footnotes
F1: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
F2: Includes shares acquired pursuant to a dividend reinvestment feature.
F3: Balance in the Abbott Laboratories Stock Retirement Trust as of June 1, 2018.
More from ABBOTT LABORATORIES
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23